SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-316334
Filing Date
2020-12-14
Accepted
2020-12-14 06:05:53
Documents
12
Period of Report
2020-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d89058d8k.htm 8-K 27769
2 EX-99.1 d89058dex991.htm EX-99.1 14203
3 EX-99.2 d89058dex992.htm EX-99.2 10940
4 GRAPHIC g89058ex99_2s1g1.jpg GRAPHIC 139647
5 GRAPHIC g89058ex99_2s2g1.jpg GRAPHIC 504432
6 GRAPHIC g89058ex99_2s3g1.jpg GRAPHIC 271382
7 GRAPHIC g89058ex99_2s4g1.jpg GRAPHIC 312017
8 GRAPHIC g89058ex99_2s5g1.jpg GRAPHIC 359548
9 GRAPHIC g89058ex99_2s6g1.jpg GRAPHIC 369710
10 GRAPHIC g89058ex99_2s7g1.jpg GRAPHIC 260500
11 GRAPHIC g89058ex99_2s8g1.jpg GRAPHIC 84316
12 GRAPHIC g89058page6.jpg GRAPHIC 3817
  Complete submission text file 0001193125-20-316334.txt   3230213
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 201385003
SIC: 2836 Biological Products, (No Diagnostic Substances)